| Xia, Bing |
| Recruiting | 3 | 315 | RoW | TQB2450, Anlotinib, TQB2450(blank), Anlotinib(blank) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Stage III Non-small-cell Lung Cancer | 12/22 | 03/25 | | |
NCT04636593: A Phase 2 Trial of Almonertinib With Concurrent Radiotherapy in The Treatment of Local Advanced EGFR-mutant NSCLC |
|
|
| Recruiting | 2 | 43 | RoW | Almonertinib, Thoracic Radiotherapy | First People's Hospital of Hangzhou, Hangzhou Cancer Hospital | Non Small Cell Lung Cancer, Stage III NSCLC, EGFR Activating Mutation | 12/21 | 12/22 | | |
HZCH-2019-004, NCT04757779: A Single-arm, Phase Ⅱ Clinical Trial of Anlotinib Hydrochloride Combined With Irinotecan or Docetaxel for Second Line Treatment of Nonsensitive Relapsed Small-cell Lung Cancer |
|
|
| Recruiting | 2 | 40 | RoW | anlotinib hydrochloride combined with irinotecan or docetaxel | First People's Hospital of Hangzhou | Relapsed Small Cell Lung Cancer, Anlotinib | 12/22 | 12/24 | | |
NCT05520853: SBRT Combined With PD-1 Inhibitor and Thoracic Hyperthermia for Advanced NSCLC |
|
|
| Recruiting | 2 | 63 | RoW | SBRT combined with PD-1 inhibitors and thoracic hyperthermia | First People's Hospital of Hangzhou, Hangzhou Cancer Hospital | Stereotactic Body Radiation Therapy; PD-1 Inhibitor; Hyperthermia; NSCLC | 12/24 | 12/24 | | |
NCT06224738: Human HER2-targeted Macrophages Therapy for HER2-positive Advanced Gastric Cancer With Peritoneal Metastases |
|
|
| Not yet recruiting | 1 | 9 | RoW | human HER2-targeted CAR-M cells, anti-HER2 CAR-M cells | First People's Hospital of Hangzhou, Macera therapeutics | Gastric Cancer | 03/25 | 03/26 | | |
NCT06536400: Phase I Study of HSK42360 in Solid Tumors With BRAF V600 Mutation |
|
|
| Recruiting | 1 | 316 | RoW | HSK42360 | Haisco Pharmaceutical Group Co., Ltd. | Solid Tumors | 08/26 | 07/27 | | |
| Oliveira, Laurie De |
NCT04892017: A Phase 1/2 Study of DCC-3116 in Patients With RAS/MAPK Pathway Mutant Solid Tumors |
|
|
| Recruiting | 1/2 | 144 | US | DCC-3116, Trametinib, Binimetinib, Sotorasib | Deciphera Pharmaceuticals, LLC | Non-Small Cell Lung Cancer, Advanced Solid Tumor, Metastatic Solid Tumor | 08/27 | 08/28 | | |
